Biomarkers of response to ocrelizumab in relapsing–remitting multiple sclerosis

Autor: Fernando Rodríguez-Jorge, José Ignacio Fernández-Velasco, Noelia Villarrubia, Julia Gracia-Gil, Eva Fernández, Virginia Meca-Lallana, Carolina Díaz-Pérez, Susana Sainz de la Maza, Eva María Pacheco, Ana Quiroga, Lluis Ramió-Torrentà, Sergio Martínez-Yélamos, Laura Bau, Enric Monreal, Ana López-Real, Alexander Rodero-Romero, Laura Borrega, Santiago Díaz, Pablo Eguía, Mercedes Espiño, Juan Luis Chico-García, Francisco Javier Barrero, María Luisa Martínez-Ginés, José Manuel García-Domínguez, Soraya De la Fuente, Irene Moreno, Raquel Sainz-Amo, M. Alba Mañé-Martínez, Ana Caminero, Fernando Castellanos, Ana Gómez López, Andrés Labiano-Fontcuberta, Lucía Ayuso, Rossana Abreu, Miguel Ángel Hernández, José Meca-Lallana, Lorena Martín-Aguilar, Alfonso Muriel García, Jaime Masjuan, Lucienne Costa-Frossard, Luisa María Villar

Publikováno v: Frontiers in Immunology, Vol 15 (2024)

ObjectiveTo ascertain the changes of serum neurofilament light chain (sNfL) and glial fibrillary acidic protein (sGFAP) values in relapsing–remitting multiple sclerosis (RRMS) patients treated with ocrelizumab and their association with treatment r

Externí odkaz: https://doaj.org/article/d000198e5e11421c9eafc7ac50f33ed2

Symptom Severity in Early-stage Relapsing Remitting Multiple Sclerosis (P5-3.009)

Autor: Susana Sainz de la Maza, Rocío Gómez-Ballesteros, Mónica Borges, Jesús Martín-Martínez, Javier Sotoca, Ana Alonso, Ana B. Caminero, Laura Borrega, José L. Sánchez-Menoyo, Francisco J. Barrero-Hernández, Carmen Calles, Luis Brieva, María R. Blasco-Quílez, Julio Dotor Garcia-Soto, María del Campo-Amigo, Laura Navarro-Cantó, Eduardo Agüera, Moisés Garcés-Redondo, Olga Carmona, Laura Gabaldón-Torres, Lucía Forero, Mariona Hervás, Jorge Maurino, Tamara Castillo-Trivino

Publikováno v: Monday, April 24.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0089023646e63c5118b88a25a308d21a
https://doi.org/10.1212/wnl.0000000000203162

Long-term prognosis communication preferences in early-stage relapsing-remitting multiple sclerosis

Autor: Tamara Castillo-Triviño, Rocío Gómez-Ballesteros, Mónica Borges, Jesús Martín-Martínez, Javier Sotoca, Ana Alonso, Ana B. Caminero, Laura Borrega, José L. Sánchez-Menoyo, Francisco J. Barrero-Hernández, Carmen Calles, Luis Brieva, María R. Blasco-Quílez, Julio Dotor García-Soto, María del Campo-Amigo, Laura Navarro-Cantó, Eduardo Agüera, Moisés Garcés-Redondo, Olga Carmona, Laura Gabaldón-Torres, Lucía Forero, Mariona Hervás, Jorge Mauriño, Susana Sainz de la Maza

Publikováno v: Multiple Sclerosis and Related Disorders
r-FISABIO. Repositorio Institucional de Producción Científica
instname

Background: Multiple sclerosis is one of the most common causes of neurological disability in young adults with major consequences for their future lives. Improving communication strategies on prognosis may help patients deal with the disease and adj

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::77398d9ccef2b31dda2ff6a97b573ecc
https://hdl.handle.net/10668/22397

Tolerability and safety of dimethyl fumarate in relapsing multiple sclerosis: a prospective observational multicenter study in a real-life Spanish population

Autor: Susana Sainz de la Maza, Israel Thuissard, Andy Castro, Lucienne Costa-Frossard, Carmen Muñoz, Carlos López de Silanes, Julia Sabin, Hugo Martín, Yolanda Aladro, Ignacio Casanova, Irene Moreno, M Luisa Martínez-Ginés, Mayra Gómez-Moreno, Victoria Galan, Sarai Urtiaga, Lucía Ayuso, Elena Rodríguez-García, Celia Oreja-Guevara, Belen Pilo, Pedro Sánchez, Virginia Meca-Lallana, J.A. García-Merino, Laura Borrega, Alberto Lozano, Judit Díaz-Díaz

Publikováno v: Journal of Neurology. 267:2362-2371

Dimethyl fumarate (DMF) tolerability and safety in multiple sclerosis (MS) has been analyzed in randomized clinical trials. Real-life studies are needed to assess possible harms of this therapy in a wider MS population. To evaluate DMF tolerability,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1fe69e36e011ba058e80fab4196ca64f
https://doi.org/10.1007/s00415-020-09848-7

Risk and outcomes of COVID-19 in patients with multiple sclerosis

Autor: Elena Rodríguez García, Clara Aguirre, Julia Sabín Muñoz, Mayra Gómez Moreno, Aida Orviz García, Virginia Meca Lallana, Juan Pablo Cuello, Susana Sainz de la Maza, Luisa María Villar-Guimerans, Laura Borrega Canelo, Mercedes Espiño, Guillermo Fernández-Dono, Lucienne Costa-Frossard, María Luisa Martínez Ginés, Alba Cárcamo, Carlos López de Silanes de Miguel, Francisco Valenzuela Rojas, Irene Moreno-Torres, Rosario Blasco, Carmen Santiuste, Ignacio Casanova, Fernando Pérez Parra, Victor Elvira, Elda Maria Alba Suarez, José Manuel García Domínguez, Celia Oreja-Guevara, Enric Monreal, Yolanda Aladro

Publikováno v: Moreno-Torres, I, Lallana, V M, Costa-Frossard, L, Oreja-Guevara, C, Aguirre, C, Suárez, E M A, Moreno, M G, Canelo, L B, Muñoz, J S, Aladro, Y, Cárcamo, A, García, E R, Cuello, J P, Monreal, E, Sainz de la Maza, S, Pérez Parra, F P P, Valenzuela Rojas, F, López de Silanes de Miguel, C, Casanova, I, Martínez Gines, M L, Blasco, R, García, A O, Villar-Guimerans, L M, Fernández-Dono, G, Elvira, V, Santiuste, C, Espiño, M & García Domínguez, J M 2021, ' Risk and outcomes of COVID-19 in patients with multiple sclerosis ', European Journal of Neurology, vol. 28, no. 11, pp. 3712-3721 . https://doi.org/10.1111/ene.14990
European Journal of Neurology

Background and purpose Limited information is available on incidence and outcomes of COVID‐19 in patients with multiple sclerosis (MS). This study investigated the risks of SARS‐CoV‐2 infection and COVID‐19‐related outcomes in patients with

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ae7299d6f820bb39d813d496929552e
https://hdl.handle.net/20.500.11820/5c78a1b6-11af-46d2-b885-58869838c58a